Joint call to action urges individuals, providers and insurers to increase access to and utilization of low-dose CT screening for those at high risk for lung cancer Contact: Eileen Teves, 210-450-7239, tevese@uthscsa.edu SAN ANTONIO (Nov. 1, 2022) – Lung cancer is the leading cause of cancer death in the United States, accounting for almost 25% of […]

Reuben S. Harris, PhD, professor and chair in the Department of Biochemistry and Structural Biology at the University of Texas Health Science Center at San Antonio (UT Health San Antonio), has received a UT System Faculty Science and Technology Acquisition and Retention (STARs) award in the amount of $1.5 million to establish his laboratory, assist […]

An internationally recognized physician-scientist of Mays Cancer Center at UT Health San Antonio, together with SignalRx Pharmaceuticals Inc., have secured two National Cancer Institute business grants to further develop drugs on a pathway to first-in-human cancer clinical trials. The clinical translational researcher, Daruka Mahadevan, MD, PhD, division chief of hematology and medical oncology at UT […]

Structural racism, rather than disease, leads to inequities, authors write Contacts: Will Sansom, (210) 567-2579, sansom@uthscsa.edu Steven Lee, (210) 450-3823, lees22@uthscsa.edu SAN ANTONIO (March 28, 2022) — Black patients with cancer experienced significantly worse outcomes after COVID-19 diagnosis than non-Hispanic white cancer patients in a study published March 28 in JAMA Network Open. Investigators of […]

The UT Health San Antonio School of Dentistry has partnered with The Oral Cancer Foundation to host The San Antonio Oral Cancer Walk on Saturday, April 23, in observance of the 22nd Annual Oral Cancer Awareness Month.

A New Ovarian Cancer Clinical Trial at UT Health San Antonio MD Anderson Cancer Center is Investigating Efficacy of Surgical Pathways for Women Harboring High-Risk BRCA1 Genetic Mutations Women harboring mutations in the BRCA1 gene face an incredibly high risk of developing ovarian cancer during their lifetime and much higher risks for peritoneal cancer and […]

ERX-41, developed by UT Health San Antonio scientists, exploits a previously unrecognized weakness in breast cancer and other solid tumors. Media contact: Will Sansom, 210-567-2579, Sansom@uthscsa.edu SAN ANTONIO (June 2, 2022) – A compound, developed by a team including scientists from The University of Texas Health Science Center at San Antonio, kills a range of hard-to-treat cancer […]

In honor of cancer survivor’s month, I thought I would share some tips about getting back to exercise after cancer treatment. I also would encourage anyone battling cancer to read these tips, as early research suggests that physical activity during cancer treatment may improve symptoms related to cancer and its treatment. It may also enhance recovery […]

In a special section of the June 17, 2022, San Antonio Business Journal, experts from Mays Cancer Center at UT Health San Antonio discuss the broad scope of cancer patient care and lifesaving research taking place daily at the center and its value to the local community and regional economy.

Contact: Eileen Teves, 210-450-7239, tevese@uthscsa.edu SAN ANTONIO (June 13, 2022) – In late April, American Cancer Society (ACS) awarded the Mays Cancer Center, home to UT Health San Antonio MD Anderson Cancer Center, two check donations in the amounts of $480,000 for an institutional research grant and $65,000 for cancer support grants. Both checks were […]